Previous Close | 0.0698 |
Open | 0.0685 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0685 - 0.0701 |
52 Week Range | 0.0630 - 0.1600 |
Volume | |
Avg. Volume | 41,698 |
Market Cap | 9.893M |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3300 |
Earnings Date | Jun 12, 2024 - Jun 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of cannabis brands in key strategic U.S. markets, today announced that Etain will open its first co-located adult-use and medical dispensary in White Plains, New York.
RIV Capital Inc. ("RIV Capital") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of cannabis brands in key strategic U.S. markets, today announced that the New York Cannabis Control Board (the "CCB") approved Etain, LLC's (the "Company") transition to an adult-use operator with cultivation, processing, distribution, and retail operations.
RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, today released its financial results for the three and six months ended September 30, 2023. As previously announced, due to a change in the Company's fiscal year end from March 31st to December 31st, the Company's current fiscal year consists of three quart